FDA's Regulatory Mismatch Stalls Mental Health AI Innovation

Kintsugi's shutdown exposes a fundamental contradiction in healthcare AI regulation: while voice-based depression detection could improve mental health screening for millions who avoid clinical assessments, FDA approval frameworks designed for static medical devices make commercialization economically unfeasible. This regulatory mismatch between traditional devices and adaptive AI systems threatens to delay innovation in mental health diagnostics and beyond.